Consistent with the observation that silencing TCF7L1 and TCF7L2 reduced tumor size, their downregulation reduced SCC cell proliferation in vitro and in vivo (Figure 3—figure supplement 1). The gene discussed is TCF7L2; the disease is neoplasm.